A. Resch

Strategies to improve the quality of survival for childhood brain tumour survivors.

Stefan Rutkowski, Beate Timmermann, Andreas Wiener, 2015, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatment

U. Bode, R. Kortmann, A. V. von Bueren, 2020, PloS one.

Recent developments and current concepts in medulloblastoma.

S. Rutkowski, Carsten Friedrich, K. Hoff, 2014, Cancer treatment reviews.

Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapy.

M. Bremer, T. Pietsch, R. Kortmann, 2014, International journal of radiation oncology, biology, physics.

Quality of survival and cognitive performance in children treated for medulloblastoma in the PNET 4 randomized controlled trial.

J. Grill, G. Dellatolas, A. Wiener, 2017, Neuro-oncology practice.

Neuropsychological Outcome of Children Treated for Standard Risk Medulloblastoma in the PNET4 European Randomized Controlled Trial of Hyperfractionated Versus Standard Radiation Therapy and Maintenance Chemotherapy.

J. Grill, G. Dellatolas, R. Kortmann, 2015, International journal of radiation oncology, biology, physics.

Questionnaire-based reports of Quality of Survival and direct assessments of cognitive performance in children treated for medulloblastoma in the PNET 4 randomized controlled trial

J. Grill, G. Dellatolas, R. Kortmann, 2017 .

Neuropsychological outcome of children treated for standard risk medulloblastoma in the PNET 4 European randomised controlled trial of hyperfractionated ( HFRT ) versus standard radiotherapy ( STRT ) and maintenance chemotherapy

J. Grill, G. Dellatolas, S. Rutkowski, 2015 .